Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Merck
McKinsey
Baxter
Johnson and Johnson

Last Updated: June 8, 2023

Zydus Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for ZYDUS, and what generic and branded alternatives to ZYDUS drugs are available?

ZYDUS has two hundred and seventy-seven approved drugs.

There are twenty-seven tentative approvals on ZYDUS drugs.

Summary for Zydus
US Patents:0
Tradenames:235
Ingredients:234
NDAs:277
Patent Litigation for Zydus: See patent lawsuits for Zydus

Drugs and US Patents for Zydus

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc TOPIRAMATE topiramate CAPSULE;ORAL 078877-001 Oct 14, 2009 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms EXEMESTANE exemestane TABLET;ORAL 202602-001 Oct 3, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 206536-003 Nov 20, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms TOFACITINIB tofacitinib citrate TABLET, EXTENDED RELEASE;ORAL 214264-002 Aug 19, 2021 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms Usa Inc DIPYRIDAMOLE dipyridamole TABLET;ORAL 040874-002 Jan 28, 2008 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms BUMETANIDE bumetanide TABLET;ORAL 202900-002 Apr 30, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms DOXYCYCLINE doxycycline TABLET;ORAL 209582-003 Sep 28, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Mallinckrodt
Moodys
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.